GLP-1 receptor agonists, primarily used for diabetes and obesity, are emerging as promising treatments for alcohol use disorder due to their influence on the brain's reward system
"It's a real one that is impacting your bottom line." Balancing access and cost Most employers cover GLP-1s for diabetes, but 67% of those surveyed by the Business Group on Health also cover them for weight management
Best Places to Buy Research-Grade BPC-157 in 2026 Here are the three direct research vendors that come up most often when researchers look for this peptide, ranked by the strength of their lab proof and how easy they are to order from
2 Exercise Specialists are assigned to members once they indicate via a standard PAR-Q assessment that it is safe to exercise
L., Parthsarathy, V., Faivre, E
If resting heart rate is consistently above 100 bpm or blood pressure is above 140/90, contact your provider immediately